Literature DB >> 1404213

Breast cancer and liver metastases--incidence, diagnosis and outcome.

C J Twelves, S M O'Reilly, M A Richards.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1404213      PMCID： PMC1293614     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Phase II study of mitoxantrone for liver metastases from breast cancer.

Authors:  S M O'Reilly; R E Coleman; R D Rubens
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival.

Authors:  S M O'Reilly; M A Richards; R D Rubens
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

3.  Epirubicin in breast cancer patients with liver metastases and abnormal liver biochemistry: initial weekly treatment followed by rescheduling and intensification.

Authors:  C J Twelves; M A Richards; P Smith; R D Rubens
Journal:  Ann Oncol       Date:  1991-10       Impact factor: 32.976

4.  Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry.

Authors:  C J Twelves; S M O'Reilly; R E Coleman; M A Richards; R D Rubens
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.